Case File
efta-01480435DOJ Data Set 10OtherEFTA01480435
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-01480435
Pages
1
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
Page I of 2
Malhan, Vinu (Exchange)
From:
Deuel, Deborah (Exchange)
Sent:
Friday. March 30, 2007 10:55 AM
To:
Malhan, Vinu (Exchange)
Subject: FW: Jeepers. Inc.
From: DKIESQ@aol.com [mailto:DKIESQ@aol.com)
Sent: Friday, March 30, 2007 10:51 AM
To: Zicherman, Ira (Exchange)
Subject: Jeepers, Inc.
Mr. Ira Zicherman
Bear Stearns
Dear Mr. Zicherman:
This is to certify that Financial Trust Company, Inc.(Bear Stearns Acct No. 03866056), a USVI corporation, is
the sole stockholder of Jeepers, Inc. (Bear Steams Acct No. 03800152), which is also a USVI corporation. As
you know, Jeffrey E. Epstein (Bear Stearns Acct No. 03828825) is the sole stockholder of Financial Trust
Company, Inc. and, through his holdings of Financial Trust Company, Inc. stock, is the beneficial owner of
Jeepers, Inc.
Please feel free to contact me if you require further information.
Darren K. Indyke
Attorney-At-Law
457 Madison Avenue
4th Floor
New York, New York 10022
Tel: 212-750-1176
Fax: 212-750-0381
e-mail: dkiesq@aol.com
IRS Circular 230 Legend: Any advice contained herein was not intended or written to be used, and cannot be
used, for the purpose of avoiding U.S. federal, state, or local tax penalties. Unless otherwise specifically
indicated above, you should assume that any statement in this email relating to any U.S. federal, state, or local
tax matter was written in connection with the promotion or marketing by other parties of the transaction(s) or
matter(s) addressed in this email. Each taxpayer should seek advice based on the taxpayer's particular
circumstances from an independent tax advisor.
Confidentiality Notice: This communication and any attachments contain information from Darren K. lndyke,
Esq. that constitute attorney work product or that are otherwise confidential and/or privileged. Except for
personal use by the intended recipient, or as expressly authorized by the sender, any person who receives this
information is prohibited from disclosing, copying, distributing, and/or using it. If you have received this
communication in error, please immediately delete it and all copies, and promptly notify the sender at the above
telephone number or electronic mail address. Nothing in this communication is intended to operate as an
electronic signature under applicable law.
Confidential Treatment Requested by
JPMorgan Chase
rnnirnpNTIAL
JPM-SDNY-00002594
SDNY_GM_00271792
EFTA01480435
Technical Artifacts (7)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Email
dkiesq@aol.comFax
Fax: 212-750-0381Phone
212-750-0381Phone
212-750-1176Phone
3800152Phone
3828825Phone
3866056Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
OtherUnknown
FEDWIRE PAYMENT DEBIT ADVICE
DOJ EFTA Data Set 10 document EFTA01273102
16p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.